Company Financials: Neurocrine Biosciences, Inc. - Aarkstore Enterprise market reserach report.
02/13/2010

Aarkstore announce a new report "Company Financials: Neurocrine Biosciences, Inc. " through its vast collection of market reserach report.

Online PR News – 13-February-2010 – – Introduction

The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. THIS PRODUCT HAS BEEN DESIGNED FOR DELIVERY IN A DATAPACK FORMAT (.XLS). PLEASE SELECT THE DATAPACK OPTION FROM THE DOWNLOAD MENU.

Scope

*Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation

*Provides key ratios

*Includes information on revenue distribution by business segments and geographies

Highlights

Neurocrine Biosciences (Neurocrine) is a biopharmaceutical company engaged in producing drugs for the treatment of neurological and endocrine related diseases and disorders.

The company's are used for curing diseases and disorders, including insomnia, anxiety, depression, various female and male health disorders, diabetes and other neurological and endocrine related diseases and disorders.

Reasons to Purchase

*Access important financial information and analysis on the company in a single datapack

*Understand the financial evolution of the company over the last five years

*Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization

For more information, please visit :

www.aarkstore.com/reports/Company-Financials-Neurocrine-Biosciences-Inc--37535.html